Novozymes invests 14% of revenue in research and development. Enzymes receive the bulk of our research resources, while the balance is used for microorganisms and other areas outside enzymes. In these areas we leverage our biotechnology competencies to deliver bio solutions to - among others - the biopharmaceutical industry. Using our existing competencies, we are exploring new business opportunities based on our core technologies: Fermentation and the production of proteins.
Progress driven by unconventional thinking
Our research and development efforts are based on the latest thinking, newest technologies, and most efficient world-class organization techniques. Through close collaborations with customers and partners we deploy our methods and talent base to develop innovative products that help our customers achieve higher profitability and improved environmental sustainability. Our cross-functional approach and world-class technology base mean that we are often able to apply the latest developments from one industry or area to overcome challenges in another. And by building on our cross-industry insights we can best anticipate the future needs of our customers.
A history built on new ideas
The facts speak for themselves: Every major innovation in enzymes over the course of the last 40 years has been achieved by Novozymes. Novozymes also boasts the highest number of filed patents within bio innovation in the EU.